DMBA/TPA-induced tumor formation is aggravated in human papillomavirus type 16 E6/E7 transgenic mouse skin

Oncology Research

Volumn 16, Issue 7, 2007, Pages 325-332

  Kim, Myoung Ok ^a   Kim, Sung Hyun ^a   Shin, Mi Jung ^a   Yu, Dong Hoon ^a   Kim, Bong Soo ^a   Chang, Kyu Tae ^b   Lee, Sanggyu ^a   Park, Yong Bok ^a   Lee, Tae Hoon ^c   Ryoo, Zae Young ^a  

^a Kyungpook National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

DMBA TPA; hK14 promoter; HPV16 E6 E7; Keratinocytes; Skin cancer; Transgenic mice

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN E6; PROTEIN E7; 7,12 DIMETHYLBENZ[A]ANTHRACENE; 8-HYDROXY-2'-DEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; EPIDERMIS CELL; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; TRANSGENIC MOUSE; ANIMAL; C3H MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DERMIS; DRUG EFFECT; EPIDERMIS; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SKIN; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; DEOXYGUANOSINE; DERMIS; DNA DAMAGE; EPIDERMIS; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 34250346021     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783980964     Document Type: Article

References (26)

1. zur Hausen, H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49:4677-4681; 1989.
2. Dyson, N.; Howley, P. M.; Muger, K.; Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937; 1989.
3. Werness, B. A.; Levine, A. J.; Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79; 1990.
4. Li, X.; Coffino, P. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Gen. Virol. 70:4509-4516; 1996.
5. Farnham, P. J.; Slansky, K. E.; Kollmar, R. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta 155:125-131; 1993.
6. Goodrich, D. W.; Wang, N. P.; Qian, Y.; Lee, E. H.; Lee, W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302; 1991.
7. Kuerbitz, S. J.; Plunkett, B. S.; Walsh, W. V.; Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495; 1992.
8. Slebos, R. J.; Lee, M. H.; Plunkett, B. S.; Kessis, T. D.; Williams, B. O.; Jacks, T.; Hedrick, L.; Kastan, M. B.; Cho, K. R. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91:5320-5324; 1994.
9. Demers, G. W.; Foster, S. A.; Halbert, C. L.; Galloway, D. A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA 91:4382-4386; 1994.
10. Hickman, E. S.; Picksley, S. M.; Vousden, K. H. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene 9:2177-2181; 1994.
11. Lee, W. T.; Lee, J. E.; Lee, S. H.; Jang, H. S.; Giffard, R. G.; Park, K. A. Human papilloma virus type 16 E7 genes protect astrocytes against apoptotic and necrotic death induced by hydrogen peroxide. Yonsei Med. J. 42: 471-479; 2001.
12. Chen, Q. M.; Merrett, J. B.; Dilley, T.; Purdom, S. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: An apoptosis-like cell death associated with mitosis. Oncogene 21:5313-5324; 2002.
13. Arbeit, J. M.; Munger, K.; Howley, P. M.; Hanahan, D. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am, J. Pathol. 142:1187-1197; 1993.
14. Sasagawa, T.; Kondoh, G.; Inoue, M.; Yutsudo, M.; Hakura, A. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes. J. Gen. Virol. 75:3057-3065; 1994.
15. Searle, P. F.; Thomas, D. P.; Faulkner, K. B.; Tinsley, J. M. Stomach cancer in transgenic mice expressing human papillomavirus type 16 early region genes from a keratin promoter. J. Gen. Virol. 75:1125-1137; 1994.
16. Kim, S. H.; Kim, K. S.; Lee, E. J.; Kim, M. O.; Park, J. H.; Cho, K. I.; Imakawa, K.; Hyun, B. H.; Chang, K. T.; Lee, H. T.; Ryoo, Z. Y. Human keratin 14 driven HPV 16 E6/E7 transgenic mice exhibit hyperkeratinosis. Life Sci. 75:3035-3042; 2004.
17. Julia, R.; Gerhard, F.; Thomas, M. M. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J. Invest. Dermatol. 123:973-981; 2004.
18. Quintanilla, M.; Brown, K.; Ramsden, M.; Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80; 1986.
19. Zhao, Y.; Xue, Y.; Oberley, T. D.; Kiningham, K. K.; Lin, S. M.; Yen, H. C.; Majima, H.; Hines, J.; St. Clair, D. Overexpression of manganese Superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 61:6082-6088; 2001.
20. Howes, K. A.; Ransom, N.; Papermaster, D. S.; Lasudry, J. G.; Albert, D. M.; Windle, J. J. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8:1300-1310; 1994.
21. Pan, H.; Griep, A. E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes Dev. 8:1285-1299; 1994.
22. Herber, R.; Liem, A.; Pilot, H.; Lambert, P. F. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70:1873-1881; 1996.
23. Hennings, H.; Glick, A. B.; Lowry, D. T.; Krsmanovic, L. S.; Sly, L. M.; Yuspa, S. H. FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14:2353-2358; 1993.
24. Brown, K.; Buchmann, A.; Baimain, A. Carcinogeninduced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA 87:538-542; 1990.
25. Beckman, J. K.; Bagheri, F.; Ji, C.; Blair, I. A.; Marnett, L. J. Phospholipid peroxidation in tumor promoter-exposed mouse skin. Carcinogenesis 15:2937-2944; 1994.
26. Nakamura, Y.; Torikai, K.; Ohto, Y.; Murakami, A.; Tanaka, T.; Ohigashi, H. A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: Dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase. Carcinogenesis 21:1899-1907; 2000.